Retail News

FDA pulls Zantac, other heartburn meds off the market

CNN 04/01/2020

The U.S. Food and Drug Administration has ordered all manufacturers and retailers to pull all prescription and over-the-counter ranitidine drugs, known by the brand name Zantac, from the market immediately after discovering a contaminant in the heartburn medication. The contaminant, N-nitrosodimethylamine or NDMA, is a probable carcinogen in humans.

 

MORE ON THIS STORY...

MORE RETAIL NEWS HEADLINES...

Discussions
Check out RetailWire's Engaging Online Discussions Featuring Our Exclusive Braintrust!